Discomfort on breathing support flags ICU death risk in immunocompromised patients
A post-hoc analysis of a French and Italian trial found that early discomfort on noninvasive support and solid cancer were ...
A post-hoc analysis of a French and Italian trial found that early discomfort on noninvasive support and solid cancer were ...
A post hoc analysis of a phase III trial found that a birch-pollen-derived sublingual immunotherapy tablet reduced symptom and medication ...
A post hoc analysis of the TRAILBLAZER-ALZ 2 trial found that lower baseline amyloid, older age, fewer APOE ε4 alleles ...
A post hoc analysis of the ATTR-ACT trial found that 64 percent of tafamidis-treated patients maintained walking-distance stability at 12 ...
A seven-year follow-up of the PROTECT HER2 trial found that prophylactic carvedilol offered no significant long-term cardiovascular benefit in early-stage ...
A post hoc analysis of the ATTR-ACT trial and its long-term extension found continuous tafamidis treatment significantly reduced cardiovascular death ...
A post-hoc analysis of the JADE COMPARE and JADE EXTEND trials found that abrocitinib produced early and sustained skin clearance ...
A post hoc analysis of the ATTR-ACT trial found that early increases in TTR concentration after tafamidis treatment were associated ...
Post-hoc analyses of the Swedish MISTRAL trial show that body image distress and weight worries increased significantly in both women ...
A pooled analysis of two trials found consistent zuranolone effects across Japanese patient subgroups, with sleep symptoms contributing most to ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine